Xiaohong M. Han

Beijing Key Laboratory Of Key Technologies For Early Clinical Trial Evaluation Of Innovative Drugs For Major Diseases, Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District
Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 173 publications

Dose Exploration Based on Quantitative Pharmacokinetic Analysis of Monoclonal Antibodies for Pediatric Immune-Mediated Diseases: Current Evidence and Future Directions.

Dose Exploration Based on Quantitative Pharmacokinetic Analysis of Monoclonal Antibodies for Pediatric Immune-Mediated Diseases: Current Evidence and Future Directions.

Journal: Drug design, development and therapy

Published: May 25, 2026

Development and validation of an HPLC-MS/MS method for the quantification of Aficamten in human plasma and urine and application to a clinical pharmacokinetic study.

Development and validation of an HPLC-MS/MS method for the quantification of Aficamten in human plasma and urine and application to a clinical pharmacokinetic study.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: May 24, 2026

Development Trends of Janus Kinase Inhibitors (JAKi) Over Three Decades: From Common to Rare Diseases.

Development Trends of Janus Kinase Inhibitors (JAKi) Over Three Decades: From Common to Rare Diseases.

Journal: Drug design, development and therapy

Published: January 18, 2026

Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in real-world patients with pulmonary embolism in China.

Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in real-world patients with pulmonary embolism in China.

Journal: Research and practice in thrombosis and haemostasis

Published: December 21, 2025

Decoding tumor-associated autoantibodies in liver cancer: Mechanisms, clinical applications, and detection methods.

Decoding tumor-associated autoantibodies in liver cancer: Mechanisms, clinical applications, and detection methods.

Journal: Autoimmunity reviews

Published: November 10, 2025

DSG2+ Cancer Stem Cells Co-Located With FAP+ Myofibroblasts in the Tumor Boundary That Determines the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.

DSG2+ Cancer Stem Cells Co-Located With FAP+ Myofibroblasts in the Tumor Boundary That Determines the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 31, 2025

Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancer.

Spatial transcriptomics reveals molecular heterogeneity and subtype-specific therapeutic targets in small cell lung cancer.

Journal: NPJ precision oncology

Published: July 17, 2025

Reply: Reevaluating PCA and SCTransform usage in single-cell intrahepatic cholangiocarcinoma analysis.

Reply: Reevaluating PCA and SCTransform usage in single-cell intrahepatic cholangiocarcinoma analysis.

Journal: Hepatology (Baltimore, Md.)

Published: July 14, 2025

iPSC-derived exosomes promote diabetic wound healing by attenuating inflammatory responses.

iPSC-derived exosomes promote diabetic wound healing by attenuating inflammatory responses.

Journal: Stem cell research & therapy

Published: July 09, 2025

Outcomes of robotic prostatectomy with lymph node removal and early hormone therapy for locally advanced prostate cancer (pT3-4N0-1M0).

Outcomes of robotic prostatectomy with lymph node removal and early hormone therapy for locally advanced prostate cancer (pT3-4N0-1M0).

Journal: BMC urology

Published: May 10, 2025

Development of derivatization-enhanced EIEIO-driven glycosidic linkage sequencing (DEED-GL-Seq) strategy and its application to glycogen-sourced oligosaccharides profiling.

Development of derivatization-enhanced EIEIO-driven glycosidic linkage sequencing (DEED-GL-Seq) strategy and its application to glycogen-sourced oligosaccharides profiling.

Journal: Carbohydrate polymers

Published: April 03, 2025

Multi-omics unveils BCAA metabolism markers L-leucine and HMGCS1 as prognostic marker for immunotherapy efficacy in non-small cell lung cancer.

Multi-omics unveils BCAA metabolism markers L-leucine and HMGCS1 as prognostic marker for immunotherapy efficacy in non-small cell lung cancer.

Journal: Respiratory research

Published: March 22, 2025

Showing 1-12 of 173

Last Updated: 09/26/2026